Your browser doesn't support javascript.
loading
Vitamin B6 in plasma and cerebrospinal fluid of children.
Albersen, Monique; Bosma, Marjolein; Jans, Judith J M; Hofstede, Floris C; van Hasselt, Peter M; de Sain-van der Velden, Monique G M; Visser, Gepke; Verhoeven-Duif, Nanda M.
Afiliação
  • Albersen M; Department of Medical Genetics, University Medical Center (UMC) Utrecht, Utrecht, The Netherlands.
  • Bosma M; Department of Medical Genetics, University Medical Center (UMC) Utrecht, Utrecht, The Netherlands.
  • Jans JJ; Department of Medical Genetics, University Medical Center (UMC) Utrecht, Utrecht, The Netherlands.
  • Hofstede FC; Department of Paediatric Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center (UMC) Utrecht, Utrecht, The Netherlands.
  • van Hasselt PM; Department of Paediatric Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center (UMC) Utrecht, Utrecht, The Netherlands.
  • de Sain-van der Velden MG; Department of Medical Genetics, University Medical Center (UMC) Utrecht, Utrecht, The Netherlands.
  • Visser G; Department of Paediatric Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center (UMC) Utrecht, Utrecht, The Netherlands.
  • Verhoeven-Duif NM; Department of Medical Genetics, University Medical Center (UMC) Utrecht, Utrecht, The Netherlands.
PLoS One ; 10(3): e0120972, 2015.
Article em En | MEDLINE | ID: mdl-25760040
BACKGROUND: Over the past years, the essential role of vitamin B6 in brain development and functioning has been recognized and genetic metabolic disorders resulting in functional vitamin B6 deficiency have been identified. However, data on B6 vitamers in children are scarce. MATERIALS AND METHODS: B6 vitamer concentrations in simultaneously sampled plasma and cerebrospinal fluid (CSF) of 70 children with intellectual disability were determined by ultra performance liquid chromatography-tandem mass spectrometry. For ethical reasons, CSF samples could not be obtained from healthy children. The influence of sex, age, epilepsy and treatment with anti-epileptic drugs, were investigated. RESULTS: The B6 vitamer composition of plasma (pyridoxal phosphate (PLP) > pyridoxic acid > pyridoxal (PL)) differed from that of CSF (PL > PLP > pyridoxic acid > pyridoxamine). Strong correlations were found for B6 vitamers in and between plasma and CSF. Treatment with anti-epileptic drugs resulted in decreased concentrations of PL and PLP in CSF. CONCLUSION: We provide concentrations of all B6 vitamers in plasma and CSF of children with intellectual disability (±epilepsy), which can be used in the investigation of known and novel disorders associated with vitamin B6 metabolism as well as in monitoring of the biochemical effects of treatment with vitamin B6.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vitamina B 6 / Deficiência Intelectual / Anticonvulsivantes Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vitamina B 6 / Deficiência Intelectual / Anticonvulsivantes Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article